Press Release: Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
CAMBRIDGE, Mass., March 28, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced positive results from the Phase 2 part of the AMETHYST Phase 2/3 study (Part A) of litifilimab in people living with cutaneous lupus erythematosus (CLE). Litifilimab is the first humanized IgG1 monoclonal antibody (mAb) targeting blood dendritic cell antigen 2 (BDCA2), which…
Dubai, UAE, March 28, 2026 (GLOBE NEWSWIRE) -- Pepeto presale crossed $8.47 million after its latest presale round closed ahead of schedule, and the crypto news connecting this project to the BNB price prediction tells a story every BNB holder needs to understand.
Largo, FL, March 28, 2026 (GLOBE NEWSWIRE) -- This release reflects growing consumer discussions and publicly available information surrounding the viral "gelatin trick" trend in 2026. It is intended for informational purposes and does not represent independent product testing, evaluation, or third-party review of any product referenced. All product details described below are stated as…
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hitek Global Inc. (NASDAQ: HKIT) resulting from allegations that Hitek Global Inc. may have issued materially misleading business information to the investing public.
Baltimore, MD, March 28, 2026 (GLOBE NEWSWIRE) -- Jim Rickards, the economist and former CIA advisor who has spent five decades at the intersection of Wall Street and Washington, has released a new video presentation making the case that artificial intelligence — the most hyped investment story of this era — may be generating risks that…
